Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

A woman with lupus had blood cell destruction, treated successfully with medication.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Selenium therapy improved health in cystic fibrosis patients with fewer side effects at a lower dose.

SLE should be considered when investigating the cause of a stroke to prevent more strokes.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The new minoxidil and salicylic acid hydrogel improves alopecia treatment.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Early diagnosis and treatment of calcinosis cutis in lupus patients is crucial due to its rarity and potential complications.

Adalimumab can cause complete hair loss in rare cases.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.